BARBARA, LUIGI
 Distribuzione geografica
Continente #
AS - Asia 1.878
NA - Nord America 1.532
EU - Europa 754
SA - Sud America 191
AF - Africa 77
Totale 4.432
Nazione #
US - Stati Uniti d'America 1.489
SG - Singapore 615
VN - Vietnam 431
CN - Cina 382
HK - Hong Kong 208
BR - Brasile 153
SE - Svezia 139
DE - Germania 97
NL - Olanda 95
IT - Italia 88
RU - Federazione Russa 64
IE - Irlanda 57
GB - Regno Unito 54
FR - Francia 49
JP - Giappone 43
IN - India 42
KR - Corea 39
BG - Bulgaria 38
CA - Canada 24
CI - Costa d'Avorio 23
SC - Seychelles 22
AR - Argentina 21
FI - Finlandia 19
PH - Filippine 19
MX - Messico 16
CH - Svizzera 14
BD - Bangladesh 13
ID - Indonesia 12
TG - Togo 11
UA - Ucraina 11
IQ - Iraq 10
JO - Giordania 10
ZA - Sudafrica 10
TH - Thailandia 9
AT - Austria 8
IR - Iran 7
PK - Pakistan 7
PL - Polonia 7
BH - Bahrain 6
ES - Italia 6
TR - Turchia 6
TW - Taiwan 6
EC - Ecuador 5
CO - Colombia 4
PY - Paraguay 4
CL - Cile 3
UZ - Uzbekistan 3
BE - Belgio 2
ET - Etiopia 2
KE - Kenya 2
LT - Lituania 2
NG - Nigeria 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
BF - Burkina Faso 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
IS - Islanda 1
KZ - Kazakistan 1
MU - Mauritius 1
MY - Malesia 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SY - Repubblica araba siriana 1
Totale 4.432
Città #
Singapore 350
San Jose 244
Santa Clara 218
Hong Kong 197
Ashburn 147
Ho Chi Minh City 117
Chandler 114
Hanoi 96
Boardman 89
Beijing 82
Dublin 57
Princeton 48
Los Angeles 42
Southend 38
Sofia 34
Hefei 29
Tokyo 29
Seoul 28
Lauterbourg 26
New York 26
São Paulo 26
Abidjan 23
Berlin 22
Buffalo 18
Helsinki 18
Redondo Beach 16
Bologna 15
Guangzhou 15
Bern 14
Da Nang 14
Dallas 14
Frankfurt am Main 13
Haiphong 13
Chicago 12
Falkenstein 12
Houston 11
Lomé 11
Milan 11
Shanghai 11
Amman 10
Amsterdam 9
Columbus 9
Mexico City 9
Montreal 9
Nuremberg 9
Boston 8
Hangzhou 8
Mumbai 8
Salt Lake City 8
Yubileyny 8
Council Bluffs 7
Warsaw 7
Bengaluru 6
Denver 6
Fairfield 6
Kyiv 6
Long Xuyen 6
Manila 6
Phoenix 6
Turin 6
Bangkok 5
Belo Horizonte 5
Biên Hòa 5
Bowie 5
Fuzhou 5
Hải Dương 5
London 5
Manama 5
Manaus 5
Quận Bình Thạnh 5
San Francisco 5
Shenzhen 5
Washington 5
Xi'an 5
Campinas 4
Chennai 4
Hưng Yên 4
Kunming 4
Munich 4
Olalla 4
Ottawa 4
Reggio Emilia 4
Rio de Janeiro 4
Salvador 4
Shijiazhuang 4
Taiyuan 4
The Dalles 4
Thái Nguyên 4
Tianjin 4
Tân Tiến 4
Vũng Tàu 4
Wuhan 4
Brooklyn 3
Bến Tre 3
Cambridge 3
Can Tho 3
Cape Town 3
Chengdu 3
Düsseldorf 3
Jinan 3
Totale 2.623
Nome #
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 275
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 255
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 118
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 108
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 108
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 106
Interleukin 1 in ulcerative colitis 106
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 105
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 104
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 103
Role of rectal formulations: Enemas 100
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 99
Macrophage subpopulations in pouchitis 97
Bronchopulmonary involvement in ulcerative colitis 97
Cost-effectiveness analysis of the preparation of colonoscopy. Comparison between a PEG-electrolyte solution and a standard preparation 95
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 95
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 93
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 91
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 90
Pentasa in maintenance treatment of ulcerative colitis 89
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 89
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 87
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration 84
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 83
Rifaximin suspension for the eradication of helicobacter pylori 72
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 70
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 62
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 61
Familial adenomatous polyposis and inflammatory bowel disease associated in two kindreds 59
Rifaximin suspension for the eradication of helicobacter pylori 58
Effects of Dietary Fat on Postprandial Gastrointestinal Motility Are Inhibited by a Cholecystokinin Type A Receptor Antagonist 57
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 57
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 54
The susceptibility of helicobacter pylori to the rifamycin, rifaximin 50
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 48
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 47
The susceptibility of helicobacter pylori to the rifamycin, rifaximin 44
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 44
Serological response to Helicobacter pylori in gastric and non-gastric cancer 44
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 43
Serological response to Helicobacter pylori in gastric and non-gastric cancer 42
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 42
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 41
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 40
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 40
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 40
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 37
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 36
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 34
Peptic ulcer disease and Helicobacter pylori infection 29
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 29
Peptic ulcer disease and Helicobacter pylori infection 29
Optimal nutritional indexes in gastroenterology 28
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 27
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 27
Source of Helicobacter pylori Infection 26
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 25
Lactose Malabsorption in Adult Patients with Crohn's Disease 25
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 24
Biliary surgery without the surgeon! 23
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 22
Helicobacter pylori: its role in gastric disease 21
Treatment of symptom-free Helicobacter pylori-positive subjects 20
Prevalence of Helicobacter pylori in military barracks 18
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 18
Helibacter pylori and gastroduodenal disease 18
Helicobacter pylori and other spiral organisms in gastroduodenal disease 18
Helicobacter pylori: its role in gastric disease 18
Helicobacter pylori and acid-related diseases of the stomach: mechanisms of pathogenesis 17
Pathogenic mechanisms of acid-related diseases: Helicobacter and other spiral organisms 17
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors 17
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors 17
Helicobacter pylori and acid-related diseases of the stomach: mechanisms of pathogenesis 17
Helicobacter pylori and other spiral organisms in gastroduodenal disease 17
Screening for Helicobacter pylori 16
Biliary surgery without the surgeon! 16
Helibacter pylori and gastroduodenal disease 15
Prevalence of Helicobacter pylori in military barracks 13
Source of Helicobacter pylori Infection 13
Treatment of symptom-free Helicobacter pylori-positive subjects 12
Pathogenic mechanisms of acid-related diseases: Helicobacter and other spiral organisms 12
Totale 4.543
Categoria #
all - tutte 17.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022258 0 1 1 4 2 1 1 2 81 33 100 32
2022/2023525 48 76 51 28 28 37 17 39 99 19 32 51
2023/2024270 73 33 23 24 21 49 6 22 3 13 3 0
2024/20251.097 41 81 63 59 322 50 89 37 10 109 22 214
2025/20262.384 134 181 247 168 248 100 167 206 551 223 72 87
Totale 4.543